SOLFRIZZI, Vincenzo
 Distribuzione geografica
Continente #
NA - Nord America 20.678
AS - Asia 6.794
EU - Europa 4.903
SA - Sud America 1.899
AF - Africa 273
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 4
Totale 34.590
Nazione #
US - Stati Uniti d'America 20.430
SG - Singapore 2.796
CN - Cina 1.545
BR - Brasile 1.510
HK - Hong Kong 949
IT - Italia 702
SE - Svezia 700
DE - Germania 651
RU - Federazione Russa 647
UA - Ucraina 503
FR - Francia 501
FI - Finlandia 443
VN - Vietnam 416
GB - Regno Unito 295
IN - India 222
BD - Bangladesh 154
AR - Argentina 138
NL - Olanda 133
CA - Canada 111
ID - Indonesia 99
IQ - Iraq 87
MX - Messico 80
TR - Turchia 80
EC - Ecuador 67
PK - Pakistan 67
ZA - Sudafrica 64
IE - Irlanda 63
CO - Colombia 56
JP - Giappone 49
SA - Arabia Saudita 46
CI - Costa d'Avorio 42
MA - Marocco 42
PL - Polonia 41
VE - Venezuela 40
UZ - Uzbekistan 38
AU - Australia 35
BE - Belgio 35
AT - Austria 33
KE - Kenya 31
PH - Filippine 31
MY - Malesia 30
ES - Italia 23
EG - Egitto 22
RO - Romania 21
CL - Cile 20
PY - Paraguay 20
TN - Tunisia 20
UY - Uruguay 18
IR - Iran 17
LT - Lituania 17
PE - Perù 17
JM - Giamaica 16
KR - Corea 15
CH - Svizzera 14
DZ - Algeria 14
AE - Emirati Arabi Uniti 13
ET - Etiopia 13
JO - Giordania 13
NP - Nepal 13
OM - Oman 13
GR - Grecia 12
KZ - Kazakistan 12
TH - Thailandia 12
AL - Albania 11
IL - Israele 11
PS - Palestinian Territory 11
RS - Serbia 10
BO - Bolivia 9
LB - Libano 7
PA - Panama 7
AZ - Azerbaigian 6
CR - Costa Rica 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
TW - Taiwan 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
KH - Cambogia 5
PT - Portogallo 5
SN - Senegal 5
TT - Trinidad e Tobago 5
AO - Angola 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
BY - Bielorussia 4
GY - Guiana 4
KG - Kirghizistan 4
KW - Kuwait 4
MD - Moldavia 4
PR - Porto Rico 4
QA - Qatar 4
BB - Barbados 3
BH - Bahrain 3
HN - Honduras 3
HR - Croazia 3
MN - Mongolia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
CM - Camerun 2
EU - Europa 2
Totale 34.548
Città #
Fairfield 2.575
Woodbridge 2.045
Ashburn 1.991
Singapore 1.474
Houston 1.381
Chandler 1.256
Jacksonville 1.120
Seattle 1.108
Hong Kong 934
San Jose 918
Ann Arbor 887
Cambridge 857
Wilmington 782
Nyköping 551
Beijing 396
Dallas 316
Roxbury 296
Lawrence 294
Lauterbourg 290
Nanjing 286
New York 261
Los Angeles 251
Des Moines 208
Helsinki 168
Boardman 163
Bari 150
Ho Chi Minh City 124
São Paulo 120
Santa Clara 115
Princeton 112
Buffalo 106
Hanoi 103
Munich 103
San Diego 99
Brooklyn 94
Nanchang 68
Shenyang 64
Council Bluffs 63
Falkenstein 61
Inglewood 61
Dearborn 56
Hebei 56
Dublin 55
London 55
Moscow 53
Rio de Janeiro 53
Jiaxing 50
Frankfurt am Main 48
Paris 48
Jakarta 47
San Francisco 43
Abidjan 42
Chicago 42
Strasbourg 39
Dong Ket 38
Nuremberg 38
Tianjin 38
Changsha 37
Ostuni 36
Tokyo 36
Pune 35
Brussels 34
Milan 34
Ruvo Di Puglia 32
Toronto 32
Washington 32
Belo Horizonte 31
Phoenix 31
Tashkent 31
Atlanta 30
Warsaw 30
Baghdad 29
Rome 29
Curitiba 28
Mexico City 28
Montreal 28
Quito 27
Brasília 26
Redwood City 26
Johannesburg 25
Nairobi 25
Orem 25
Chennai 24
Porto Alegre 23
Shanghai 23
Guangzhou 22
Amsterdam 21
Columbus 21
Denver 21
The Dalles 21
Boston 20
Mumbai 19
Stockholm 19
Jeddah 18
Medellín 18
Norwalk 18
San Mateo 18
Charlotte 17
Fortaleza 17
Campinas 16
Totale 24.165
Nome #
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 501
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 352
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 271
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 241
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 235
Dietary patterns, foods, and food groups: Relation to late-life cognitive disorders 228
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 226
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 215
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 209
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 200
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 200
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 196
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 195
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 195
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 193
Epidemiology of age related hearing loss: A review 190
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 184
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 182
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 180
Age-related changes of serum N-acetyl-aspartate in healthy controls. 177
Dietary intervention and prevention of cognitive-related outcomes in healthy older adults without cognitive dysfunction 177
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 173
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 173
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome 173
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants 171
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 170
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 169
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 167
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 159
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 159
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 158
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 158
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 158
Cognitive frailty: a potential target for secondary prevention of dementia 158
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 158
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? 156
Alcohol consumption, mild cognitive impairment, and progression to dementia 156
Nutritional interventions in patients with Alzheimer’s disease and other late-life cognitive disorders 154
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 153
Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: A systematic review and meta-analysis of individual participant data 152
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 150
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 149
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys 149
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 147
Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease 147
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 147
A rehabilitation program for mild memory impairments. 146
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia 146
. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging 145
Analysis of some aspects of learning and memorization processes in an adult population. 144
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 144
Alcohol drinking, cognitive functions in older age, predementia, and dementia syndromes 144
Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease [7] 142
Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy 142
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 141
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 141
Agreement of a short form of the self-administered multidimensional prognostic index (SELFY-MPI-SF): A useful tool for the self-assessment of frailty in community-dwelling older people 140
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 139
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 139
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 137
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease 137
A century of trends in adult human height 137
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 137
Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants 137
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 136
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 136
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries 136
Nutritional domains in frailty tools: Working towards an operational definition of nutritional frailty 136
Mediterranean diet and cognitive decline 135
Cognitive frailty: Predementia syndrome and vascular risk factors 135
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 135
Alcohol Consumption in Predementia and Dementia Syndromes 134
Time to test antibacterial therapy in Alzheimer's disease 134
Nutrition, frailty, and Alzheimer's disease. 133
Vascular risk factors, alcohol intake, and cognitive decline 132
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia 130
S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease 130
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 129
Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment 129
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 129
Liver fibrosis score, physical frailty, and the risk of dementia in older adults: The Italian longitudinal study on aging 129
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 128
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 128
Dietary unsaturated fatty acids and risk of mild cognitive impairment 126
Aluminium in the diet, cognitive decline and dementia. 126
All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a) 125
Metabolic syndrome, mild cognitive impairment, and dementia 123
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 123
Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease 123
. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians 122
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease 121
. Mediterranean diet in predementia and dementia syndromes.REview 121
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational Study 120
Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging 120
Nutritional factors, cognitive decline, and dementia 120
Current epidemiology of mild cognitive impairment and other predementia syndromes2 120
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging 120
Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians 119
Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia 119
Assessment of sense of taste in Italian centenarians 119
Totale 15.830
Categoria #
all - tutte 132.613
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.613


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021177 0 0 0 0 0 0 0 0 0 0 0 177
2021/20221.838 64 165 12 67 101 183 71 88 152 134 320 481
2022/20233.153 507 300 214 303 379 402 34 367 489 20 79 59
2023/20241.116 105 189 74 72 93 247 55 65 38 47 16 115
2024/20254.931 92 78 448 174 72 430 391 418 274 290 715 1.549
2025/20269.675 1.497 419 715 1.199 1.152 652 1.259 339 1.010 943 481 9
Totale 35.363